Investor Relations

NYSE: NVRO

Price

96.51 +0.00 ( +0% ) 5:00 2/22/17 Pricing delayed 20 minutes

Volume 467,700

Recent News

See All
February 9, 2017 Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016
Nevro to Host Conference Call on Thursday, February 23, 2017 at 1:30 p.m. PT / 4:30 p.m. ET Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it will release financial results for the fourth quarter and full year of 2016 after market close on Thursday, February 23, 2017 . Company management will host a conference call beginning at 1:30 p.m. Pacific Time ( 4:30 p.m. Eastern Time ) on Thursday, February 23, 2017 . Investors interested in listening to the conference call may do so by dialing (877) 201-0168 for U.S. callers, or (647) 788-4901 for international callers (Conference ID: 65198382), or from the webcast on the "Investors" section of the Company's website at www.nevro.com/investors. Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company's website. About Nevro Headquartered in Redwood City, California , Nevro...
December 22, 2016 Nevro to Present at the 35th Annual J.P. Morgan Healthcare Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting at the 35 th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 in San Francisco. Nevro management is scheduled to present at 11:00 a.m. PT.  The presentation will be accessible via a live audio webcast, accessible in the "Investors" section of the company's website at: http://www.nevro.com/Investors. Following the presentation, an archived copy will be available on the Investor Events and Presentations webpage of the Company's website. About Nevro Headquartered in Redwood City, California , Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based...

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza System is the only SCS system that delivers Nevro's proprietary HF10™ therapy. Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro.

Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro Corp.